Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Le Bert

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Gut and Liver|January 11, 2018
Immunotherapy for Chronic Hepatitis B Virus InfectionAntonio Bertoletti, Nina Le Bert
Hepatology Communications|October 9, 2019
Fine-Tuning TLR-7-Based Therapy for Functional HBV CureAntonio Bertoletti, Nina Le Bert
Immunology and Cell Biology|January 22, 2014
Advances in NKG2D ligand recognition and responses by NK cellsNina Le Bert, Stephan Gasser
Cellular & Molecular Immunology|January 14, 2024
Silent battles: immune responses in asymptomatic SARS-CoV-2 infectionNina Le Bert, Taraz Samandari
Oxford Open Immunology|April 16, 2024
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective roleAntonio Bertoletti, Anthony T Tan, Nina Le Bert
Immunity|September 1, 2022
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemicAntonio Bertoletti, Nina Le Bert, Anthony T Tan
Methods in Molecular Biology (Clifton, N.J.)|July 23, 2024
Ex Vivo Fluorescent Labeling of HBV-Specific B Cells in Chronic Hepatitis B PatientsLoghman Salimzadeh, Alice R Burton, Nina Le Bert
International Journal of Molecular Sciences|September 23, 2022
Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue LocalizationAntonio Bertoletti, Nina Le Bert, Anthony T Tan
Gut|November 28, 2025
Decoding HBV-specific adaptive immunity: from natural clearance to cureRobert Thimme, Maike Hofmann, Antonio Bertoletti, et al.
Plos One|April 13, 2011
DC priming by M. vaccae inhibits Th2 responses in contrast to specific TLR2 priming and is associated with selective activation of the CREB pathwayNina Le Bert, Benjamin M Chain, Graham Rook, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Gut and Liver|January 11, 2018
Immunotherapy for Chronic Hepatitis B Virus InfectionAntonio Bertoletti, Nina Le Bert
Hepatology Communications|October 9, 2019
Fine-Tuning TLR-7-Based Therapy for Functional HBV CureAntonio Bertoletti, Nina Le Bert
Immunology and Cell Biology|January 22, 2014
Advances in NKG2D ligand recognition and responses by NK cellsNina Le Bert, Stephan Gasser
Cellular & Molecular Immunology|January 14, 2024
Silent battles: immune responses in asymptomatic SARS-CoV-2 infectionNina Le Bert, Taraz Samandari
Oxford Open Immunology|April 16, 2024
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective roleAntonio Bertoletti, Anthony T Tan, Nina Le Bert
Immunity|September 1, 2022
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemicAntonio Bertoletti, Nina Le Bert, Anthony T Tan
Methods in Molecular Biology (Clifton, N.J.)|July 23, 2024
Ex Vivo Fluorescent Labeling of HBV-Specific B Cells in Chronic Hepatitis B PatientsLoghman Salimzadeh, Alice R Burton, Nina Le Bert
International Journal of Molecular Sciences|September 23, 2022
Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue LocalizationAntonio Bertoletti, Nina Le Bert, Anthony T Tan
Gut|November 28, 2025
Decoding HBV-specific adaptive immunity: from natural clearance to cureRobert Thimme, Maike Hofmann, Antonio Bertoletti, et al.
Plos One|April 13, 2011
DC priming by M. vaccae inhibits Th2 responses in contrast to specific TLR2 priming and is associated with selective activation of the CREB pathwayNina Le Bert, Benjamin M Chain, Graham Rook, et al.
Pageof 6